Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 6
2021 9
2022 6
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Restriction spectrum imaging with elastic image registration for automated evaluation of response to neoadjuvant therapy in breast cancer.
Andreassen MMS, Loubrie S, Tong MW, Fang L, Seibert TM, Wallace AM, Zare S, Ojeda-Fournier H, Kuperman J, Hahn M, Jerome NP, Bathen TF, Rodríguez-Soto AE, Dale AM, Rakow-Penner R. Andreassen MMS, et al. Front Oncol. 2023 Sep 15;13:1237720. doi: 10.3389/fonc.2023.1237720. eCollection 2023. Front Oncol. 2023. PMID: 37781199 Free PMC article.
ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging.
Lui AJ, Kallis K, Zhong AY, Hussain TS, Conlin C, Digma LA, Phan N, Mathews IT, Do DD, Domingo MR, Karunamuni R, Kuperman J, Dale AM, Shabaik A, Rakow-Penner R, Hahn ME, Seibert TM. Lui AJ, et al. Int J Radiat Oncol Biol Phys. 2023 Dec 1;117(5):1145-1152. doi: 10.1016/j.ijrobp.2023.07.004. Epub 2023 Jul 14. Int J Radiat Oncol Biol Phys. 2023. PMID: 37453559
The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis.
Salans M, Houri J, Karunamuni R, Hopper A, Delfanti R, Seibert TM, Bahrami N, Sharifzadeh Y, McDonald C, Dale A, Moiseenko V, Farid N, Hattangadi-Gluth JA. Salans M, et al. PLoS One. 2023 Feb 17;18(2):e0279812. doi: 10.1371/journal.pone.0279812. eCollection 2023. PLoS One. 2023. PMID: 36800342 Free PMC article.
Response to Haiman, Kote-Jarai, Darst et al.
Seibert TM, Pagadala MS, Lynch J, Karunamuni R, Carter H, Rose BS, Hauger RL. Seibert TM, et al. J Natl Cancer Inst. 2023 Mar 9;115(3):343-344. doi: 10.1093/jnci/djad006. J Natl Cancer Inst. 2023. PMID: 36629482 Free PMC article. No abstract available.
Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations.
Motazedi E, Cheng W, Thomassen JQ, Frei O, Rongve A, Athanasiu L, Bahrami S, Shadrin A, Ulstein I, Stordal E, Brækhus A, Saltvedt I, Sando SB, O'Connell KS, Hindley G, van der Meer D, Bergh S, Nordestgaard BG, Tybjærg-Hansen A, Bråthen G, Pihlstrøm L, Djurovic S, Frikke-Schmidt R, Fladby T, Aarsland D, Selbæk G, Seibert TM, Dale AM, Fan CC, Andreassen OA. Motazedi E, et al. J Alzheimers Dis. 2022;88(4):1533-1544. doi: 10.3233/JAD-220174. J Alzheimers Dis. 2022. PMID: 35848024 Free PMC article.
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.
Huynh-Le MP, Karunamuni R, Fan CC, Asona L, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir KR, Lophatananon A, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Nordestgaard BG, Tangen CM, MacInnis RJ, Wolk A, Albanes D, Haiman CA, Travis RC, Blot WJ, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Menegaux F, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Lu YJ, Watya S, Vega A, Kogevinas M, Wiklund F, Penney KL, Huff CD, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, De Ruyck K, Ost P, Razack A, Newcomb LF, Fowke JH, Gamulin M, Abraham A, Claessens F, Castelao JE, Townsend PA, Crawford DC, Petrovics G, van Schaik RHN, Parent MÉ, Hu JJ, Zheng W; UKGPCS collaborators; APCB (Australian Prostate Cancer BioResource); NC-LA PCaP Investigators; IMPACT Study Steering Committee and Collaborators; Canary PASS Investigators; Profile Study Steering Committee; PRACTICAL Consortium; Mills IG, Andreassen OA, Dale AM, Seibert TM. Huynh-Le MP, et al. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):755-761. doi: 10.1038/s41391-022-00497-7. Epub 2022 Feb 12. Prostate Cancer Prostatic Dis. 2022. PMID: 35152271 Free PMC article.
24 results